Psychopharmacological Boundaries of Schizophrenia with Comorbid Cannabis Use Disorder: A Critical Review

E-ISSN： 1873-4286|18|32|4890-4896

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.32, 2012-11, pp. : 4890-4896

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Schizophrenia and Comorbid Substance Use Disorder

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 2, 2002-04 ,pp. : 129-139

Bentham Science Publishers

Access to resources Recommend Favorite

Aripiprazole: A Review of its Use in Schizophrenia and Schizoaffective Disorder

By Tracy Swainston Harrison Caroline M. Perry

Drugs, Vol. 64, Iss. 15, 2004-01 ,pp. : 1715-1736

Adis International

Access to resources Recommend Favorite

Ziprasidone: A Review of its Use in Schizophrenia and Schizoaffective Disorder

By Tracy Swainston Harrison Scott Lesley J.

CNS Drugs, Vol. 20, Iss. 12, 2006-01 ,pp. : 1027-1052

Adis International

Access to resources Recommend Favorite

Ziprasidone: A Review of its Use in Schizophrenia and Schizoaffective Disorder

By Gunasekara N.S. Spencer C.M. Keating G.M.

Drugs, Vol. 62, Iss. 8, 2002-01 ,pp. : 1217-1251

Adis International

Access to resources Recommend Favorite

Intervention Efficacy in Trials Targeting Cannabis Use Disorders in Patients with Comorbid Psychosis Systematic Review and Meta-analysis

Current Pharmaceutical Design, Vol. 20, Iss. 13, 2014-04 ,pp. : 2205-2211

Bentham Science Publishers

Access to resources Recommend Favorite